About CCP

The Commercializing Continuous Processing in Pharma Summit (CCP) is the only strategical continuous manufacturing meeting to unite both small and large molecule modalities, to pair technical case studies with the business-case-realities of technology innovation.  

Curated with industry leaders, this is the longest standing peer-led meeting encompassing all aspects in the integration of continuous processing in Pharma. In 2022 over 100 pioneers in continuous manufacturing came together in Boston to:

  • Showcase pilot plant to commercial scale real-world case studies, providing an industry benchmark for you and your stakeholders  
  • Give you clarity and updates on the global regulatory landscape  
  • Equip you with the latest PAT technologies and how to conduct a seamless, validated tech transfer 
  • Explore how gene therapies, vaccines and non-traditional applications can increase their stake in the continuous industry 

2 workshop sessions explored the current state of play in continuous manufacturing, first steps to implement in your organization & how to expand your continuous processing capabilities across drug portfolios, a site visit to CONTINUUS pharmaceuticals, and a jammed-packed main agenda featuring cutting-edge presentations from leading pharma and biotech. CCP attendees walked away with actionable insights o drive value in their department and company-wide, to drive down manufacturing costs and increase product quality.